Ruminations of a Taco-Obsessed Philly Native

Multiple Sclerosis is known to be a chronic progressive disease involving damage to the nervous system in the brain and spinal cord. Its symptoms vary from numbness, impairment of speech and of muscular coordination, blurred vision, to fatigue. Recently conducted clinical trial results provide evidence that high dose immunosuppressive therapy followed by transplantation of a person’s own blood-forming stem cells can induce sustained remission of relapsing-remitting multiple sclerosis (MS), an autoimmune disease in which the immune system attacks the central nervous system.

A percentage of up to 69% is known to survive for at least five years without experiencing progression of disability, relapse of MS symptoms or new brain lesions, considering the fact that patients are never put under any medication. This however, tends to change in the long run. Other studies have indicated that currently available MS drugs have lower success rates.

A medical trial, called HALT-MS, sponsored by the National Institute of Allergy and Infectious Diseases (NIAID), has been conducted to get extended findings on one-time treatment with HDIT/HCT which may be substantially more effective than long-term treatment with the best available medications for people with a certain type of Multiple Sclerosis.

The most common form of MS was established to be relapsing-remitting MS, which is characterized by periods of mild or no symptoms interspersed with symptom relapses which worsen over years. In HALT-MS, researchers tested the safety, efficacy and durability of HDIT/HCT in 24 volunteers. The experimental aimed at suppressing active disease and prevent further disability. Though the treatment had some risks associated with it, positive results were recorded in most of the volunteer patients.In case the findings are confirmed in larger studies, HDIT/HCT may become a potential therapeutic option for patients with active relapsing-remitting MS, particularly those who do not respond to existing therapies.

On the same line of specialty, shedding light to Dr. Gopal Vasishta would be of much importance as Dr. Gopal’s has committed his life to helping people living with nervous system dis-orders. Having practiced medicine and majored in neurology, his work and contribution towards finding medical solutions to multiple sclerosis and other nervous system related disorders has been a major achievement, taking the practice a milestone ahead.

Dr. Gopal Vasishta is a practicing professional Neurologist in Voorhees, who graduated from Government Medical College in 1979 and has been in practice for a period of more than 35 years, having completed a residency at Boston City Hospital. Dr. Gopal Vasishta is also a specialist in Psychiatry. He currently practices at Eastern Neurodiagnostic Associates which is affiliated with Kennedy Health System Cherry Hill Campus. He is licensed by American Board of Psychiatry and Neurology as well as Certified in Neurology NJ State Medical Licensed.

 

NO COMMENTS

You must be logged in to post a comment.